Treatment Impact on the Long-Term Ocular Outcomes in Behçet’s-Related Uveitis

References

• Behçet H. Über rezidivierende aphthöse durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152–1157.
   Google Scholar
• Zouboulis CC. Epidemiology of adamantiades-Behçet’s disease. Annales de Medecine Interne. 1999;150:488–498. PMID: 10615535.
   PubMedGoogle Scholar
• Çakar Özdal P. Özdal PÇ.Behçet’s uveitis: current diagnostic and therapeutic approach Turk. J Ophthalmol. 2020;50(3):169–182. doi:10.4274/tjo.galenos.2019.60308.
   Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380. doi:10.1016/j.ajo.2004.03.022.
   PubMed Web of Science ®Google Scholar
• Özdal PÇ, Ortaç S, Taskintuna I, Firat E. Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol. 2002;12(5):424–431. doi:10.1177/112067210201200514.
   PubMed Web of Science ®Google Scholar
• Onal S, Tugal-Tutkun I. Behçet disease. In: Biswas J Majumder P, ed(s). Uveitis: An Update. India: Springer; 2016: 17–31.
   Google Scholar
• Tugal-Tutkun I. Behçet′s uveitis. Middle East Afr J Ophthalmol. 2009;16(4):219–224. doi: 10.4103/0974-9233.58425.
   PubMedGoogle Scholar
• Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;77:808–818. doi:10.1136/annrheumdis-2018-213225.
   PubMed Web of Science ®Google Scholar
• Criteria for Diagnosis of Behçet’s Disease. International study group for Behçet’s disease. Lancet. 1990;335(8697):1078–1080. doi:10.1016/0140-6736(90)92643-V.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Abdollahi BS, Chams-Davatchi C, Shahram F, Nadji A, Shams H, et al. Validation of the revised International Criteria for Behcet’s Disease (ICBD) in Iran. Clin Rheumatol. 2015;34(2):315–320. doi:10.1007/s10067-013-2411-3.
   PubMed Web of Science ®Google Scholar
• The Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Stanford M, Akman M, Twisk JWR, Boers M, et al. An algorithm for the diagnosis of Behçet disease uveitis in adults. Ocul Immunol Inflamm. 2021;29(6):1154–1163. doi:10.1080/09273948.2020.1736310. Epub 2020 Apr 14. PMID: 32286112.
   PubMed Web of Science ®Google Scholar
• Cingu AK, Onal S, Urgancioglu M, Tugal-Tukun I. Comparison of presenting features and three-year disease course in Turkish patients with Behçet uveitis who presented in the early 1990s and the early 2000s. Ocul Immunol Inflamm. 2012;20(6):423–428. doi:10.3109/09273948.2012.713159.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Attia S, Yahia SB, Jenzeri S, Ghrissi R, Jelliti B, et al. Pattern of uveitis in Behçet’s disease in a referral center inTunisia, North Africa. Int Ophthalmol. 2009;29(3):135–141. doi:10.1007/s10792-008-9203-9.
   PubMedGoogle Scholar
• Kump LI, Moeller KL, Reed GF, Kurup SK, Nussenblatt RB, Levy-Clarke GA, et al. Behçet’s disease: comparing 3 decades of treatment response at the national eye institute. Can J Ophthalmol. 2008;43(4):468–472. doi:10.3129/i08-080.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, et al. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology. 2004;111(4):810–815. doi:10.1016/j.ophtha.2003.07.018.
   PubMed Web of Science ®Google Scholar
• Akiyama K, Numaga J, Yoshida A, Kawashima H, Kaburaki T, Fujino Y, et al. Statistical analysis of endogenous uveitis at Tokyo University Hospital (1998–2000). Jpn J Ophthalmol. 2006;50(1):69–71. doi:10.1007/s10384-005-0261-5.
   PubMed Web of Science ®Google Scholar
• Ando K, Fujino Y, Hijikata K, Izawa, Y, Masuda K. Epidemiological features and visual prognosis of Behçet’s disease. Japanese J Ophthalmology. 1999;43(4):312–317. doi:10.1016/s0021-5155(99)00029-5.
   PubMed Web of Science ®Google Scholar
• Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, et al. Ten-Year retention rate of infliximab in patients with Behçet’s disease-related uveitis. Ocul Immunol Inflamm. 2019;27(1):34–39. doi:10.1080/09273948.2017.1391297. Epub 2017 Nov 3. PMID: 29099660.
   PubMed Web of Science ®Google Scholar
• Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, et al. Efficacy of anti-TNF alpha in severe and/or refractory Behçet’s disease: multicenter study of 124 patients. J Autoimmun. 2015;62:67–74. doi:10.1016/j.jaut.2015.06.005. Epub 2015 Jul 8. PMID: 26162757.
   PubMed Web of Science ®Google Scholar
• Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular inflammation in Behçet Disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146(6):828–836. doi:10.1016/j.ajo.2008.06.019.
   PubMed Web of Science ®Google Scholar
• Kaburaki T, Araki F, Takamoto M, Okinaga K, Yoshida A, Numaga J, et al. Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol. 2010;248(5):709–714. doi: 10.1007/s00417-009-1234-z.
   PubMed Web of Science ®Google Scholar
• Sota J, Cantarini L, Vitale A, Sgheri A, Gentileschi S, Caggiano V, et al. Long-term outcomes of Behçet’s syndrome-related uveitis: a monocentric Italian experience. Mediators Inflamm. May 15, 2020;2020:6872402. doi:10.1155/2020/6872402. PMID: 32508524; PMCID: PMC7245671.
   PubMed Web of Science ®Google Scholar